Economic Considerations and Cost-Saving Strategies for Nonsterile Compounding Education.


Journal

American journal of pharmaceutical education
ISSN: 1553-6467
Titre abrégé: Am J Pharm Educ
Pays: United States
ID NLM: 0372650

Informations de publication

Date de publication:
11 2023
Historique:
received: 27 10 2022
revised: 20 06 2023
accepted: 05 07 2023
medline: 3 11 2023
pubmed: 17 7 2023
entrez: 16 7 2023
Statut: ppublish

Résumé

To determine the economic considerations, including cost-saving strategies, associated with nonsterile compounding education for students in schools and colleges of pharmacy across the United States. An electronic survey was sent to the American Association of Colleges of Pharmacy Pharmaceutics Section and Laboratory Instructor's Special Interest Group members. Quantitative and qualitative data were collected about the institution, student cohorts, compounding courses, equipment, budgets, personnel, and cost-saving measures. Descriptive statistics were calculated using SPSS. Open-ended responses were used by respondents if the primary question could not adequately capture their institution-specific information. These answers were added to the study findings. Of 555 surveys sent, 46 were completed. Reported annual compounding budgets ranged from $3000 to $96,000. Reported annual equipment maintenance costs ranged from $400 to $18,000. Fifty percent of respondents reported students shared equipment, and 29.6% collected a lab fee from students to offset costs. Approximately half of respondents reported the use of cost-saving measures, including contract pricing, purchasing supplies in bulk, price comparisons, use of simulated drugs, re-use of personal protective equipment, and procurement of donations. Fifty percent of respondents employed laboratory assistants to support nonsterile compounding sessions, with paid positions ranging from $200 to $1000 per semester. Findings from this study may assist pharmacy administrators and course directors in evaluating the costs associated with nonsterile compounding education across the Academy and, more importantly, determining ways to reduce such costs while maintaining the intent and quality of these courses.

Identifiants

pubmed: 37454811
pii: S0002-9459(23)01898-3
doi: 10.1016/j.ajpe.2023.100571
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

100571

Informations de copyright

Copyright © 2023 American Association of Colleges of Pharmacy. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jeanne E Frenzel (JE)

North Dakota State University, Fargo, ND, USA. Electronic address: Jeanne.Frenzel@ndsu.edu.

Alexis Crawford (A)

Virginia Commonwealth University, Richmond, VA, USA.

Mary E Fredrickson (ME)

Northeast Ohio Medical University, Rootstown, OH, USA.

Kyle Duale (K)

Northeast Ohio Medical University, Rootstown, OH, USA.

Rajesh Vadlapatla (R)

Marshall B. Ketchum University, Fullerton, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH